These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3447448)

  • 1. Carnitine depletion during chronic hemodialysis: effect of substitution on free carnitine plasma levels.
    Broquet PE; Von Moos C; Frei J; Gobelet C; Wauters JP
    Adv Exp Med Biol; 1987; 223():287-90. PubMed ID: 3447448
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis.
    Maebashi M; Imamura A; Yoshinaga K; Sato T; Funyu T; Ishidoya Y; Hirayama N
    Tohoku J Exp Med; 1983 Jan; 139(1):33-42. PubMed ID: 6836557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine and lipid profile in uremia.
    Savica V; Bellinghieri G
    Clin Ter; 1997; 148(5-6):229-36. PubMed ID: 9377858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients.
    Wanner C; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Am J Clin Nutr; 1990 Mar; 51(3):407-10. PubMed ID: 2309647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.
    Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C
    Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis.
    Weschler A; Aviram M; Levin M; Better OS; Brook JG
    Nephron; 1984; 38(2):120-4. PubMed ID: 6472539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis.
    Bellinghieri G; Savica V; Barbera CM; Ricciardi B; Egitto M; Torre F; Valentini G; D'Iddio S; Bagiella E; Mallamace A
    Nephron; 1990; 55(1):28-32. PubMed ID: 2141109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis.
    Sakai K; Fukami K; Yamagishi S; Kaida Y; Adachi T; Ando R; Manabe R; Otsuka A; Sugi K; Ueda S; Okuda S
    Rejuvenation Res; 2013 Jun; 16(3):200-5. PubMed ID: 23488553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?
    Bonomini M; Zammit V; Pusey CD; De Vecchi A; Arduini A
    Pharmacol Res; 2011 Mar; 63(3):157-64. PubMed ID: 21138768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-carnitine on arrhythmias during hemodialysis.
    Suzuki Y; Narita M; Yamazaki N
    Jpn Heart J; 1982 May; 23(3):349-59. PubMed ID: 6178854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis.
    Penn D; Schmidt-Sommerfeld E
    Metabolism; 1983 Aug; 32(8):806-9. PubMed ID: 6865778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
    Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
    G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1997 Jun; 97(6):534-40. PubMed ID: 9441289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine content in different muscles of patients receiving maintenance hemodialysis.
    Debska-Slizień A; Kawecka A; Wojnarowski K; Zadrony D; Kunicka D; Król E; Lysiak-Szydłowska W; Rutkowski B
    J Ren Nutr; 2007 Jul; 17(4):275-81. PubMed ID: 17586427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine deficiency induced during haemodialysis.
    Battistella PA; Angleini C; Vergani L; Bertoli M; Lorenzi S
    Lancet; 1978 Apr; 1(8070):939. PubMed ID: 76875
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced carnitine palmitoyl transferase activity and altered acyl-trafficking in red blood cells from hemodialysis patients.
    de los Reyes B; Perez-García R; Liras A; Arenas J
    Biochim Biophys Acta; 1996 Jan; 1315(1):37-9. PubMed ID: 8611644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole body fat oxidation before and after carnitine supplementation in uremic patients on chronic haemodialysis.
    Lundholm K; Persson H; Wennberg A
    Clin Physiol; 1988 Aug; 8(4):417-26. PubMed ID: 3409653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.